Chicago March 20, 2025
Christina and Jackson Agar, a Minnesota couple, have experienced remarkable weight loss success with a medication called tirzepatide. However, their journey may be coming to an end due to a decision by the Food and Drug Administration (FDA).
The Agars, who have lost around 20 pounds each in six weeks, have been taking a compounded version of tirzepatide, which is a cheaper alternative to Eli Lilly’s Zepbound. However, the FDA has declared the Zepbound shortage over and has ordered compounding pharmacies to stop making tirzepatide by Wednesday.
Since starting the medication, Christina has reported having more energy for their four kids, and Jackson no longer needs his sleep apnea machine. The couple has also noticed a significant change in their eating habits, with Jackson saying, “It is completely life-changing to take a bite of these triggering foods and just be like, enjoy it, say, ‘Yup, that was good and now I’m full.'”
